Definitive Contract 75N93024C00075

Award Date 9/30/24
Potential Completion Date 9/29/29
Potential Value $6.3M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Stanford, CA 94305, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to The Leland Stanford Junior University (Stanford University) for a biomedical research project. The contract, valued at $31,608,779.60, does not have a set-aside designation. The contract is for a "Systems Biology Approach to Infectious Diseases" and runs from September 2008 to September 2013. Stanford University, a...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to The Leland Stanford Junior University (Stanford University), a private research institution. The $19,155,153 contract is for a 5-year research program to compare multiple vaccine adjuvants and comprehensively assess the immune responses they induce. The goal is to develop "immune fingerprints" of adjuvants using advanced...
This is a $7,839,205 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University. The contract supports research related to the discovery and validation of novel human B cell epitopes that elicit antibodies associated with infectious agents, autoimmune diseases, allergic conditions, and transplant rejection/tolerance. The contract is a definitive, cost-no-fee contract with a period of...
This is a definitive contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to The Leland Stanford Junior University (Stanford University) for $378,000.00. The contract, which does not have a set-aside designation, is for computational thinking to support clinicians and biomedical scientists, and is funded through the American Recovery and Reinvestment Act (ARRA). Stanford University, a renowned private research institution, has been awarded...
This is a $36,549,202.01 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for the Immune Epitope and Analysis Program. The contract has no set-aside designation and is set to run until December 14, 2025. As the prime contractor, the La Jolla Institute for Immunology is responsible for the overall program, which involves conducting research and providing services related to...
This federal contract award, HHSN271201500760P, was issued by the National Institute on Drug Abuse, a civilian agency, to The Leland Stanford Junior University (Stanford University) for a project titled "Immunologic Function in Autism and Related Conditions." The $120,000.00 firm fixed-price contract has an ultimate completion date of September 21, 2016 and does not have a set-aside designation. Stanford University, a private non-profit research institution, is the prime contractor for...
This federal contract award was made by the Food and Drug Administration (FDA) to The Leland Stanford Junior University (Stanford University) on September 13, 2016. The contract, valued at $1,006,847.00, is for a scientific study under the Major Program Code "BAA- ACCURACY AND INTEGRATION OF LARGE SCALE DATA FROM GENOME SEQUENCING AND MOBILE SENSORS". The contract is a definitive contract with a cost no fee pricing type and has a completion date of March 31, 2020. Stanford University...
This is a Definitive Contract awarded by the Food and Drug Administration to The Leland Stanford Junior University (Stanford University) with a ceiling value of $6,296,725.48. The contract is for a BAA (Broad Agency Announcement) scientific study on the sequelae and immunopathology of Ebola virus infections. It does not have a set-aside designation. As part of this effort, Stanford has issued a subcontract to the University of California, Los Angeles (UCLA) to collect and provide blood samples...
This is a $11,665,406.62 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Washington University, a private university in St. Louis, Missouri. The contract supports "B Cell Epitope Discovery and Mechanisms of Antibody Protection" research, with no set-aside designation. The contract includes several subcontractors: Vanderbilt University Medical Center is developing panels of human monoclonal antibodies against flaviviruses and...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $398,250 firm-fixed price contract to The Leland Stanford Junior University, doing business as Stanford University, for research and development services to support a molecular diagnostic device that can continuously measure multiple biomarkers in the interstitial space. The contract has a completion date of August 5, 2022 and was awarded on September 30, 2019. The...

The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $6,331,035.00 definitive cost-no-fee contract to The Leland Stanford Junior University (Stanford University) for "Innovations in Functional B Cell Epitope Discovery". The contract is not set-aside and has a period of performance through September 29, 2029. Stanford University, a leading private research institution, will provide research and development services to NIAID focused on discovering and validating novel human B cell epitopes associated with infectious diseases, autoimmune conditions, allergies, and transplant immunology. The award stems from a pre-solicitation opportunity that anticipated issuing 2-4 cost-reimbursement contracts with an average annual value of $1.5 million. Stanford University's extensive expertise in biomedical research and long history of federal contract and grant work with agencies like NIAID make them well-positioned to execute this project.

Generated 9/27/25, 9:55 AM